Safety and efficacy of combined portal and hepatic vein embolisation in patients with colorectal liver metastases (DRAGON1): a multicentre, single-arm clinical trial.

Korenblik R, James S, Smits J, Díaz-Nieto R, Davis R, Chan BKY, Erdmann JI, Zijlstra IAJ, Arntz PJW, Kollmar O, Hoffmann MH, Vass DG, Lindsay R, Serenari M, Cappelli A, Gobardhan PD, Imani F, Suarez YF, Muños FG, Grünhagen DJ, Moelker A, Pieterman KJ, Kleeff J, Wohlgemuth WA, Herrero E, Gelabert A, Breitenstein S, Seeger N, Detry O, Gerard L, Sandström PA, Björnsson B, Aldrighetti LA, De Cobelli F, Leclercq WKG, van Baardewijk LJ, Croagh D, De Boo DW, Kingham TP, Ridouani F, Metrakos P, Valenti D, Kalil J, Fretland ÅA, Carling U, Martel G, Ryan S, Udupa V, Macdonald A, Tasse JC, Stavrou GA, Spuentrup E, Borobia FG, Criado E, Sparrelid E, Delle M, Navinés-López J, Moragues JS, Andorrà EC, Schnitzbauer A, Vogl TJ, Heil J, Primrose JN, Modi S, Fouraschen SMG, Bokkers RPH, de Boer MT, Borel Rinkes IHM, Smits MLJ, Gruenberger T, Baclija I, Billingsley KG, Madoff DC, Serrablo A, Sarriá L, Wang X, Xudong Q, Winkens B, Olde Damink SWL, Bemelmans MHA, Dewulf MJL, Binkert CA, Schadde E, van der Leij C, van Dam RM, DRAGON collaborative study group

Open source

DOI
10.1016/j.lanepe.2025.101284
Published
2025 Jun
Container
The Lancet regional health. Europe
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1016/j.lanepe.2025.101284,
  title = {Safety and efficacy of combined portal and hepatic vein embolisation in patients with colorectal liver metastases (DRAGON1): a multicentre, single-arm clinical trial.},
  author = {Korenblik R and James S and Smits J and Díaz-Nieto R and Davis R and Chan BKY and Erdmann JI and Zijlstra IAJ and Arntz PJW and Kollmar O and Hoffmann MH and Vass DG and Lindsay R and Serenari M and Cappelli A and Gobardhan PD and Imani F and Suarez YF and Muños FG and Grünhagen DJ and Moelker A and Pieterman KJ and Kleeff J and Wohlgemuth WA and Herrero E and Gelabert A and Breitenstein S and Seeger N and Detry O and Gerard L and Sandström PA and Björnsson B and Aldrighetti LA and De Cobelli F and Leclercq WKG and van Baardewijk LJ and Croagh D and De Boo DW and Kingham TP and Ridouani F and Metrakos P and Valenti D and Kalil J and Fretland ÅA and Carling U and Martel G and Ryan S and Udupa V and Macdonald A and Tasse JC and Stavrou GA and Spuentrup E and Borobia FG and Criado E and Sparrelid E and Delle M and Navinés-López J and Moragues JS and Andorrà EC and Schnitzbauer A and Vogl TJ and Heil J and Primrose JN and Modi S and Fouraschen SMG and Bokkers RPH and de Boer MT and Borel Rinkes IHM and Smits MLJ and Gruenberger T and Baclija I and Billingsley KG and Madoff DC and Serrablo A and Sarriá L and Wang X and Xudong Q and Winkens B and Olde Damink SWL and Bemelmans MHA and Dewulf MJL and Binkert CA and Schadde E and van der Leij C and van Dam RM and DRAGON collaborative study group},
  year = {2025},
  journal = {The Lancet regional health. Europe},
  doi = {10.1016/j.lanepe.2025.101284},
  url = {https://doi.org/10.1016/j.lanepe.2025.101284}
}

RIS

TY  - JOUR
TI  - Safety and efficacy of combined portal and hepatic vein embolisation in patients with colorectal liver metastases (DRAGON1): a multicentre, single-arm clinical trial.
AU  - Korenblik R
AU  - James S
AU  - Smits J
AU  - Díaz-Nieto R
AU  - Davis R
AU  - Chan BKY
AU  - Erdmann JI
AU  - Zijlstra IAJ
AU  - Arntz PJW
AU  - Kollmar O
AU  - Hoffmann MH
AU  - Vass DG
AU  - Lindsay R
AU  - Serenari M
AU  - Cappelli A
AU  - Gobardhan PD
AU  - Imani F
AU  - Suarez YF
AU  - Muños FG
AU  - Grünhagen DJ
AU  - Moelker A
AU  - Pieterman KJ
AU  - Kleeff J
AU  - Wohlgemuth WA
AU  - Herrero E
AU  - Gelabert A
AU  - Breitenstein S
AU  - Seeger N
AU  - Detry O
AU  - Gerard L
AU  - Sandström PA
AU  - Björnsson B
AU  - Aldrighetti LA
AU  - De Cobelli F
AU  - Leclercq WKG
AU  - van Baardewijk LJ
AU  - Croagh D
AU  - De Boo DW
AU  - Kingham TP
AU  - Ridouani F
AU  - Metrakos P
AU  - Valenti D
AU  - Kalil J
AU  - Fretland ÅA
AU  - Carling U
AU  - Martel G
AU  - Ryan S
AU  - Udupa V
AU  - Macdonald A
AU  - Tasse JC
AU  - Stavrou GA
AU  - Spuentrup E
AU  - Borobia FG
AU  - Criado E
AU  - Sparrelid E
AU  - Delle M
AU  - Navinés-López J
AU  - Moragues JS
AU  - Andorrà EC
AU  - Schnitzbauer A
AU  - Vogl TJ
AU  - Heil J
AU  - Primrose JN
AU  - Modi S
AU  - Fouraschen SMG
AU  - Bokkers RPH
AU  - de Boer MT
AU  - Borel Rinkes IHM
AU  - Smits MLJ
AU  - Gruenberger T
AU  - Baclija I
AU  - Billingsley KG
AU  - Madoff DC
AU  - Serrablo A
AU  - Sarriá L
AU  - Wang X
AU  - Xudong Q
AU  - Winkens B
AU  - Olde Damink SWL
AU  - Bemelmans MHA
AU  - Dewulf MJL
AU  - Binkert CA
AU  - Schadde E
AU  - van der Leij C
AU  - van Dam RM
AU  - DRAGON collaborative study group
PY  - 2025
JO  - The Lancet regional health. Europe
DO  - 10.1016/j.lanepe.2025.101284
UR  - https://doi.org/10.1016/j.lanepe.2025.101284
ER  -

APA

R, K., S, J., J, S., R, D., R, D., BKY, C., JI, E., IAJ, Z., PJW, A., O, K., MH, H., DG, V., R, L., M, S., A, C., PD, G., F, I., YF, S., FG, M., DJ, G., A, M., KJ, P., J, K., WA, W., E, H., A, G., S, B., N, S., O, D., L, G., PA, S., B, B., LA, A., F, D. C., WKG, L., LJ, V. B., D, C., DW, D. B., TP, K., F, R., P, M., D, V., J, K., ÅA, F., U, C., G, M., S, R., V, U., A, M., JC, T., GA, S., E, S., FG, B., E, C., E, S., M, D., J, N., JS, M., EC, A., A, S., TJ, V., J, H., JN, P., S, M., SMG, F., RPH, B., MT, D. B., IHM, B. R., MLJ, S., T, G., I, B., KG, B., DC, M., A, S., L, S., X, W., Q, X., B, W., SWL, O. D., MHA, B., MJL, D., CA, B., E, S., C, V. D. L., RM, V. D., & group, D. C. S. (2025). Safety and efficacy of combined portal and hepatic vein embolisation in patients with colorectal liver metastases (DRAGON1): a multicentre, single-arm clinical trial.. The Lancet regional health. Europe. https://doi.org/10.1016/j.lanepe.2025.101284

Source records